Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10962377 | Vaccine | 2016 | 7 Pages |
Abstract
The carriage prevalence remained the same 4-8Â years after vaccine introduction, but serotype replacement became almost complete. A majority of emerging NVTs in carriage showed a low invasive disease potential. Carriage studies are an important complement to invasive disease surveillance to understand the full effect of PCV vaccine programs.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Ann Lindstrand, Ilias Galanis, Jessica Darenberg, Eva Morfeldt, Pontus Naucler, Margareta Blennow, Tobias Alfvén, Birgitta Henriques-Normark, Ã
ke Ãrtqvist,